Vaxart, Inc. Income Charts

2 years of history · ending 2025-12-31 · SEC EDGAR

Source:10-K · 10-Q

Revenue, Gross Profit, Operating Income & Net Income

Margin (%)

Operating Expenses

Income Breakdown

Revenue
$237M
R&D
$202M
D&A
$9M
Operating Income
$18M
EBITDA
$27M
Interest Expense
$2M
Interest Income
Other Income/Expense
$325K
Pretax Income
$17M
Tax Provision
$476K
Net Income
$16M
Operating Margin
7.6%
Net Margin
6.9%
Effective Tax Rate
2.8%
Deferred Tax Assets
$4M
Deferred Tax Liabilities
$0
DTA Valuation Allowance
$100M
Tax Credit Carryforwards
$20M
NOL Carryforwards
$55M
ETR (Continuing Operations)
2.8%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost
$6M
Revenue YoY Variation
726.7%
Income YoY Variation
127.3%
No segment data available for this ticker. Source: quarterchart.com.